Biotech · Private company
Metacrine, Inc.
Track this companyFree. Adds Metacrine, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- EmpagliflozinPhase 2 · NASHClinicalTrials.gov · fetched Nov 12, 2026
- MET409 ActivePhase 2 · NASHClinicalTrials.gov · fetched Nov 12, 2026
- MET642Phase 2 · NASH - Nonalcoholic SteatohepatitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study to Evaluate MET642 in Patients With NASHPHASE2 · COMPLETED · started Mar 3, 2021ClinicalTrials.gov NCT04773964 · fetched Nov 12, 2026
- Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASHPHASE2 · UNKNOWN · started Dec 15, 2020ClinicalTrials.gov NCT04702490 · fetched Nov 12, 2026